US equities
|
SPCX
$166.68
▲+4.85%
NVDA
$236.62
▲+1.14%
MU
$1,064.16
▼-1.00%
TSLA
$377.77
▲+1.94%
MSFT
$525.54
▲+1.55%
SNDK
$1,711.54
▼-0.49%
INTC
$117.14
▼-1.84%
META
$745.75
▲+2.43%
SPCX
$166.68
▲+4.85%
NVDA
$236.62
▲+1.14%
MU
$1,064.16
▼-1.00%
TSLA
$377.77
▲+1.94%
MSFT
$525.54
▲+1.55%
SNDK
$1,711.54
▼-0.49%
INTC
$117.14
▼-1.84%
META
$745.75
▲+2.43%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
AlloVir, Inc. - Common Stock
(NQ:
ALVR
)
9.810
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Mar 18, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about AlloVir, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings
↗
May 11, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -...
Via
Benzinga
AlloVir Reports First Quarter 2021 Financial Results
May 06, 2021
From
AlloVir
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
